Furthermore, CCRL2 has been implicated in activating cell-intrinsic IFN-γ/STAT1 signaling in TP53-mutant AML, via JAK2-dependent and independent pathways, even in the absence of exogenous IFN-γ [28] (Figure 6G). The gene discussed is TP53; the disease is acute myeloid leukemia.